Galvanize Therapeutics raises $130m to advance ablation platforms
Galvanize Therapeutics has raised $130m to advance its pulsed electric field (PEF) ablation technologies for oncology and chronic diseases. The…
Galvanize Therapeutics has raised $130m to advance its pulsed electric field (PEF) ablation technologies for oncology and chronic diseases. The…
The US Food and Drug Administration (FDA) has granted de novo authorisation to Roche’s cobas pro i 601 platform alongside…
Alpha Tau Medical has reported positive interim results from the first-in-human REGAIN study of its Alpha diffusing alpha-emitters radiation therapy…
The US Food and Drug Administration (FDA) has cleared Molecular Designs' SimplicityDx FluA/FluB/RSV panel, marking the company's first cleared diagnostic…
Tandem Diabetes Care’s t:slim X2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology has received multiple new indication approvals…
Medical technology firm Ventric Health has agreed to a partnership with pharmacy services provider Stellus Rx to connect outpatient heart…
Argá Medtech has concluded patient enrolment for the paroxysmal atrial fibrillation (PAF) patient cohort within COHERENT-AF (NCT06784466), the pivotal investigational…
MellingMedical and CellTivity Scientific have entered into a strategic partnership to supply the latter’s Van Gogh Microscopy System across the…
Bechtel Medical's Wound VOX, a system that integrates negative pressure wound therapy and topical oxygen therapy has secured clearance from…
Colospan, a wholly owned subsidiary of Eocene, has signed its first European commercial distribution agreement with Hospital Line for its…